Finless Foods: Lab-grown fish startup that uses genetic engineering nears commercialization

| | June 27, 2018
Finless Foods hosts a tasting of edible fish grown from cells in September 2017. Image: Finless Foods
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

Finless Foods – one of a new wave of start-ups in the rapidly heating-up cultured fish arena – has raised $3.5m in a seed round that cofounder and CEO Mike Selden says will “bring us to the end of our initial R&D phase, meaning we’ll have the tools necessary to move into production pending the closing of a Series A.”

In a post on medium, Selden said the round – led by Silicon Valley-based VC rm Draper Associates – had been completed….

“The opportunity this money gives us to perfect our science and create delicious, safe, and healthy food is genuinely exciting to our entire team. We’ve already dramatically lowered cost and secured precious cellular material that will push us into rapid commercialization within years, not decades.”

As for the GMO factor, he said: “We’re not GMO [according to the ‘bioengineered’ definition enshrined in the federal GMO labeling legislation – not yet in force GMO]; we use genetic engineering in the creation of the growth factors used in our growth medium, but the proteins are not present in the final product.”

Read full, original article: Cultured fish co Finless Foods raises $3.5m, predicts “rapid commercialization within years, not decades”

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend